IL-1 Inhibition and Function of the HDL-Containing Fraction of Plasma in Patients with Stages 3 to 5 CKD.

Adriana M HungYohei TsuchidaKristen L NowakSudipa SarkarMichel ChoncholVictoria WhitfieldNatjalie SalasAnna DikalovaPatricia G YanceyJiansheng HuangMacRae F LintonT Alp IkizlerValentina Kon

Published in: Clinical journal of the American Society of Nephrology : CJASN (2019)

IL-1 blockade improves the anti-inflammatory and antioxidative properties of the HDL-containing fraction of plasma in patients with stages 3-5 CKD, including those on maintenance hemodialysis.

Keyphrases

chronic kidney disease
anti inflammatory
end stage renal disease
peritoneal dialysis